aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded in Waltham, Massachusetts, Triveni Bio is a pioneering medical organization focused on the intersection of human genetics, advanced antibody design, and precision medicine. The company's core mission is to identify novel disease targets and develop functional antibodies for treating immunological and inflammatory disorders. Utilizing a Mendelian genetics-informed precision medicine approach, Triveni Bio leverages a proprietary data platform that integrates public and private datasets to drive their innovative therapeutic solutions.
Notable figures associated with Triveni Bio include experts in genetics and biotechnology, though specific names are not provided. The company has garnered attention for its groundbreaking work in precision medicine and antibody design, positioning itself as a leader in the field. Key achievements include the development of a robust data platform for disease target identification and the advancement of new therapeutic antibodies. Triveni Bio's impact lies in its potential to revolutionize treatment options for complex immunological and inflammatory conditions.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Therapeutics, Antibodies
Technology
AI, Biotech
Tags
Biotech, Healthtech
Model Types
Software, Data
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
United States
Where is Triveni Bio's headquarters located?
Triveni Bio's headquarters is located in Waltham, MA, US.
When was Triveni Bio's last funding round?
Triveni Bio's most recent funding round was for $92M (USD) in October 2023.
How many employees does Triveni Bio have?
Triveni Bio has 6 employees as of Feb 4, 2024.
How much has Triveni Bio raised to-date?
As of July 05, 2023, Triveni Bio has raised a total of $92M (USD) since Oct 26, 2023.
Add Comparison
Total Raised to Date
$92M
USD
Last Update Oct 26, 2023
Last Deal Details
$92M
USD
Oct 26, 2023
Series A
Total Employees Over Time
6
As of Feb 2024
Triveni Bio Address
100 Beaver Street
suite 307
Waltham,
Massachusetts
02453
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts